HOME >> BIOLOGY >> NEWS
Turning down the Sun

reduction in fossil fuels might entail.

"Teller and Wood are technical optimists, and pessimists about human behaviour," says Caldeira, who saw Wood present their work in 1998, and was disturbed by the re-emergence of these Sun-blocking proposals. "My hope was to show that it wouldn't work," he says, "so people would give up on it."

Caldeira thought he saw a central flaw in all of these Sun-dimming ideas. While reducing sunlight might have an overall cooling effect on the planet as a whole, he argued, it wouldn't counteract the local heating effect from CO2. The two forces act in a completely different way on different parts of the globe. The capacity of CO2 to trap heat increases with temperature, so it's more effective near the equator. The Sun, on the other hand, shines more in the northern hemisphere in June, more in the southern hemisphere in December. Surely, thought Caldeira, these very different phenomena couldn't exactly cancel each other out? Not on a country-sized scale, or over the different seasons. Instead, he expected the winters to get warmer and the summers cooler, the poles warmer and the tropics cooler. In short, many of the problems the Earth faces from global warming-the seasons becoming more and more alike, and a variety of weird weather (New Scientist, 16 September, p 26)-would be made worse.

To try to prove his hypothesis, Caldeira went to work with his colleague Bala Govindasamy and a hefty climate-modelling program. They invented three future worlds to test. In the first, the control model, levels of atmospheric CO2 were set at just 280 parts per million-the pre-industrial value-and the Sun shone at a constant 1367 watts per square metre at the Earth's surface. In the second, there was twice as much CO2, adding an extra 4.17 watts per square metre to the Earth-bound radiation. In the final, geoengineered scenario, the doubled CO2 was countered by cutting 1.8 per cent of the Sun's light, again worth 4.17 watts per square metre.
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
19-Sep-2000


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Turning bone into nerve
2. Turning foe into friend with lentiviral vectors
3. Turning off building lights reduces bird window-kill by 83%
4. Turning blood into brain: new studies suggest bone marrow stem cells can develop into neurons in living animals
5. Turning salt and water into wine
6. UNC Researchers Reduce Arthritis Severity By Turning Off Molecular Switch
7. Turning "Unrecyclable" Waste Into Plastic Products
8. Survey Shows Students Turning To Physicians Less As Drug Abuse Increases
9. Africa At The Turning Point
10. Nitric Oxide Found To Control Cells By Turning On Genes; Suggests New Role In Health And Disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Turning down the Sun

(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: